HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uta Kraus-Tiefenbacher Selected Research

Uta Kraus-Tiefenbacher Research Topics

Disease

21Breast Neoplasms (Breast Cancer)
11/2015 - 02/2005
14Neoplasms (Cancer)
01/2013 - 04/2005
2Cardiotoxicity
05/2009 - 04/2009
2Rectal Neoplasms (Rectal Cancer)
12/2006 - 03/2005
1Ventricular Remodeling
11/2015
1Erythema
12/2012
1Hypersensitivity (Allergy)
12/2012
1Wounds and Injuries (Trauma)
01/2012
1Seroma
07/2010
1Lobular Carcinoma
07/2010
1Neoplasm Metastasis (Metastasis)
02/2010
1Endometrial Neoplasms (Endometrial Cancer)
07/2009
1Death (Near-Death Experience)
05/2009
1Brain Neoplasms (Brain Tumor)
12/2008
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
12/2008
1Fibrosis (Cirrhosis)
10/2006

Drug/Important Bio-Agent (IBA)

2Capecitabine (Xeloda)FDA Link
12/2006 - 03/2005
2Irinotecan (Camptosar)FDA LinkGeneric
12/2006 - 03/2005
1TamoxifenFDA LinkGeneric
12/2012
1Aromatase InhibitorsIBA
12/2012
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
10/2010
1Cetuximab (Erbitux)FDA Link
12/2006
1Carisoprodol (Soma)FDA LinkGeneric
10/2006

Therapy/Procedure

27Radiotherapy
01/2013 - 02/2005
10Segmental Mastectomy (Lumpectomy)
12/2012 - 04/2005
4Therapeutics
11/2015 - 10/2006
4Drug Therapy (Chemotherapy)
11/2015 - 12/2006
2Neoadjuvant Therapy
12/2006 - 03/2005
1Conformal Radiotherapy
12/2012
1Punctures
07/2010
1Kyphoplasty
02/2010
1Brachytherapy
07/2009
1Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
05/2009
1Cranial Irradiation
12/2008
1Mastectomy (Mammectomy)
09/2007
1capecitabine-irinotecan combination
03/2005